The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based Gennova Biopharmaceuticals, has received Emergency Use Authorization (EUA) from the Drug Control General of India (DCGI). This significant development has been facilitated through the Mission COVID Suraksha initiative, managed by […]
Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is the first biosimilar developed for Eli Lilly and Company’s Cetuximab, a monoclonal antibody medication used in the treatment of various types of cancer, including head and neck cancer and metastatic […]
Themis Medicare has been granted approval from the Drug Controller General of India (DCGI) for importing and commercialization of Remifentanil 1 mg/2mg Powder for Concentrate for Solution for Injection under the brand name REMITHEM. The drug has been authorized to be used as an analgesic medication for the induction and maintenance of general anesthesia during […]
Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment of moderate-to-severe Covid-19 patients needing ventilator support (NIV and mechanical ventilation). Immunocin α, which is an immuno-modulator drug, considerably cut down the risk of death in phase 3 clinical trial […]
Dr. Reddy’s Laboratories said that the Drugs Controller General of India (DCGI) has approved the single-shot Sputnik Light vaccine for restricted use in emergency situation in the country for protection against Covid-19. Sputnik Light, which is a one-dose vaccine, is the same as the first component of the two-dose Sputnik V vaccine, which contains recombinant […]
Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under the brand name — Molnaflu. The Indian pharma company had previously acquired the licensing rights for the generic version of MSD and Ridgeback Biotherapeutics’ Molnupiravir. A non-exclusive voluntary licensing agreement […]
